期刊
MOLECULAR CANCER RESEARCH
卷 9, 期 11, 页码 1462-1470出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1541-7786.MCR-11-0190
关键词
-
资金
- NIH [R01 CA103986]
- MD Anderson's Cancer Center [CA016672]
- Marilyn and Frederick R. Lummis, Jr., M.D., Fellowship in the Biomedical Sciences
Platelet-derived growth factor B (PDGF-B) and its receptor, PDGFR-beta, play a critical role in pericyte maturation; however, the mechanisms by which PDGF-B is upregulated in the tumor microenvironment remain unclear. We previously showed that upregulating stromal-derived factor, SDF-1 alpha, in VEGF(165)-inhibited Ewing's sarcoma tumors (TC/siVEGF(7-1)) induced PDGF-B mRNA expression, increased infiltration and differentiation of bone marrow cells (BMC) into pericytes and, rescued tumor growth. The purpose of this study was to investigate the mechanism by which SDF-1 alpha increased PDGF-B expression and the role of this pathway in BM-derived pericyte differentiation. We showed that SDF-1 alpha induced expression of PDGF-B mRNA and protein both in vitro and in vivo. In contrast, inhibiting SDF-1 alpha downregulated PDGF-B. We cloned the 2-kb pdgf-b promoter fragment and showed that SDF-1 alpha activates PDGF-B via a transcriptional mechanism. Chromatin immunoprecipitation showed that the ELK-1 transcription factor binds to the pdgf-b promoter in response to SDF-1 alpha. We confirmed the correlation between the SDF-1 alpha/PDGF-B pathway and the differentiation of PDGFR-beta+ BMCs into mature pericytes using an in vitro assay. These findings show that SDF-1 alpha regulates PDGF-B expression and that this regulation plays a critical role in the differentiation of PDGFR-beta+ BMCs into mature pericytes. Mol Cancer Res; 9(11); 1462-70. (C) 2011 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据